latanoprost punctal plug delivery system (L-PPDS)
/ Mati Therap
- LARVOL DELTA
Home
Next
Prev
1 to 4
Of
4
Go to page
1
March 22, 2016
Assessment of age-related eye morphology and aqueous humor flow dynamics in the DBA/2J mouse model of pigmentary glaucoma using ocular MRI and anterior chamber iPerfusion systems
(ARVO 2016)
- "...9-mo DBA animals showed a decrease in Gd accumulation (Diff 10.33 ± 2.779, p<0.01) and peak Gd intensity. Facility in DBA2J shows an average of 46% reduction from 9 to 6 mo (N=4)."
Preclinical • Glaucoma • Ophthalmology
September 30, 2016
Comparison of Latanoprost PPDS With Timolol Maleate GFS in Subjects With Ocular Hypertension or Open-Angle Glaucoma
(clinicaltrials.gov)
- P2; N=86; Active, not recruiting; Sponsor: Mati Therapeutics Inc.; Completed ➔ Active, not recruiting; Trial primary completion date: Jul 2016 ➔ Dec 2016
Enrollment closed • Trial primary completion date • Biosimilar • Cardiovascular • Glaucoma • Ophthalmology
March 23, 2016
Long-term safety and intraocular pressure lowering efficacy of latanoprostene bunod 0.024% in Japanese subjects with open-angle glaucoma or ocular hypertension: the JUPITER study
(ARVO 2016)
- P3, N=130; JUPITER (NCT01895972); "Results from this 1-year study demonstrate that LBN 0.024% qPM was safe and well tolerated and provided robust and sustained long-term IOP lowering in Japanese subjects with OAG or OHT."
P3 data • Glaucoma • Ophthalmology
March 26, 2019
High Performance All-Polymer Photodetectors via Thick Photoactive Layer Strategy.
(PubMed, ACS Appl Mater Interfaces)
- "More importantly, the resultant all-PPDs exhibited a high working frequency over 10 kHz associated with a large linear dynamic range. These findings demonstrate the great potential for practical applications of the all-PPDs developed in this work."
Journal
1 to 4
Of
4
Go to page
1